Skip to main navigation

Investor Navigation

Overview
News & Events
- Press Releases
- Events & Presentations
Stock Information
Financials
- SEC Filings
Governance
IR Resources

Press Releases

Year

27 Sep '2022

Context Therapeutics® Amends Cash Guidance, Extends Runway into Q1 2024

06 Sep '2022

Context Therapeutics® to Participate in the H.C. Wainwright 24th Annual Global Investment Conference

11 Aug '2022

Context Therapeutics® Reports Second Quarter 2022 Operating and Financial Results

02 Aug '2022

Context Therapeutics and The Menarini Group Announce Clinical Trial Collaboration and Supply Agreement to Evaluate ONA-XR and Elacestrant Combination

11 May '2022

Context Therapeutics® Reports First Quarter 2022 Operating and Financial Results

05 May '2022

Context Therapeutics® Announces Poster Presentation at the Upcoming 2022 ASCO Annual Meeting

11 Apr '2022

Context Therapeutics® Announces Encouraging Preclinical Data from Two Programs to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2022

06 Apr '2022

Context Therapeutics® to Participate in Two April 2022 Investor Conferences

23 Mar '2022

Context Therapeutics® Reports Full Year 2021 Operating and Financial Results

08 Mar '2022

Context Therapeutics® Announces Acceptance of Five Abstracts to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2022

Pagination

Current page 1
Page 2
Next page
Last page

Displaying 1 - 10 of 13

Investor Tools

Print Page
RSS Feeds
Search

Request Email Alerts

© 2022 Context Therapeutics Inc. All rights reserved.